DOYLE THOMAS JAMES — SEC insider filings

SEC reporting owner CIK 1910331. 13 insider filings on record with FilingPulse; latest filed 2026-11-18.

Transaction summary — filings shown

Covers all 13 filings on record, filed 2022-02-09 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Kura Oncology, Inc. (KURA)SVP, Finance & Accounting13—18 legs · 34,341 sh · $336,79213

Insider filings — DOYLE THOMAS JAMES

FiledFormIssuerReported transactionsSource
2026-11-184Kura Oncology, Inc. (KURA)Sale (S): 4,697 @ $7.44EDGAR
2026-09-294Kura Oncology, Inc. (KURA)Sale (S): 4,607 @ $10.50EDGAR
2026-01-274Kura Oncology, Inc. (KURA)Sale (S): 2,226 @ $8.46 · Sale (S): 1,114 @ $8.46 · Sale (S): 695 @ $8.46 · Sale (S): 2,226 @ $8.46 · Sale (S): 881 @ $8.46EDGAR
2026-01-064Kura Oncology, Inc. (KURA)Grant/award (A): 21,250 @ $0 · Grant/award (A): 42,500 (derivative) @ $0EDGAR
2025-11-144Kura Oncology, Inc. (KURA)Grant/award (A): 24,967 @ $0 · Sale (S): 4,539 @ $11.18EDGAR
2025-09-294Kura Oncology, Inc. (KURA)Grant/award (A): 24,966 @ $0 · Sale (S): 4,541 @ $8.94EDGAR
2025-01-284Kura Oncology, Inc. (KURA)Sale (S): 2,241 @ $7.87 · Sale (S): 887 @ $7.87 · Sale (S): 699 @ $7.87 · Sale (S): 1,122 @ $7.87EDGAR
2025-01-064Kura Oncology, Inc. (KURA)Grant/award (A): 21,250 @ $0 · Grant/award (A): 21,250 @ $0 · Grant/award (A): 42,500 (derivative) @ $0EDGAR
2024-01-314Kura Oncology, Inc. (KURA)Sale (S): 594 @ $17.80 · Sale (S): 761 @ $17.80 · Sale (S): 963 @ $17.80EDGAR
2024-01-044Kura Oncology, Inc. (KURA)Grant/award (A): 21,250 @ $0 · Grant/award (A): 42,500 (derivative) @ $0EDGAR
2023-02-214Kura Oncology, Inc. (KURA)Grant/award (A): 10,625 @ $0 · Grant/award (A): 63,750 (derivative) @ $0EDGAR
2023-01-314Kura Oncology, Inc. (KURA)Sale (S): 682 @ $13.89 · Sale (S): 866 @ $13.89EDGAR
2022-02-094Kura Oncology, Inc. (KURA)Grant/award (A): 8,390 @ $0 · Grant/award (A): 39,281 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-02 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1910331 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs